Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Oragenics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 28 | 29 | +1 |
| Shares | 10.5M | 10.8M | +324.8K (+3.1%) |
| Value | $3.62M | $3.06M | −$558.0K (−15.4%) |
New holders (5)
Institutions that held Oragenics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Charles Schwab Investment Management Inc | 100,778 | $35.0K | 0.00% |
| HighTower Advisors, LLC | 89,309 | $31.0K | 0.00% |
| LexAurum Advisors, LLC | 30,000 | $10.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,076 | $2.00K | 0.00% |
| Rockefeller Capital Management L.P. | 10 | $0 | 0.00% |
Sold out (4)
Institutions that held Oragenics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 30,263 | $10.0K |
| Buckingham Strategic Wealth, LLC | 27,000 | $9.00K |
| Newman Dignan & Sheerar, Inc. | 10,468 | $4.00K |
| Glassman Wealth Services | 1 | $0 |